Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. ProKidney Corp shares valued at $1,190,062 were sold by Pereira Brian JG on Nov 13 ’25. At $2.37 per share, Pereira Brian JG sold 502,136 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Pereira Brian JG sold 255,026 shares, netting a total of over 694,515 in proceeds. Following the sale of shares at $2.72 each, the insider now holds 54,333 shares.
Before that, Brian Pereira had added 675,234 shares to its account. In a trade valued at $1,823,131, the Director bought ProKidney Corp shares for $2.70 each.
As published in their initiating research note from H.C. Wainwright on December 16, 2025, ProKidney Corp [PROK] has been a Buy and the price target has been revised to $12. Analysts at BofA Securities downgraded the stock from ‘”a Neutral”‘ to ‘”an Underperform”‘ outlook in a report released in late June. As of September 30, 2024, JP Morgan has initiated its “Neutral” rating for PROK. Earlier on September 10, 2024, Guggenheim initiated its rating. Their recommendation was “a Buy” for PROK stock.
Analyzing PROK Stock Performance
On last trading session, ProKidney Corp [NASDAQ: PROK] rose 5.11% to $2.47. The stock’s lowest price that day was $2.345, but it reached a high of $2.58 in the same session. During the last five days, there has been a surge of approximately 11.26%. Over the course of the year, ProKidney Corp shares have jumped approximately 34.24%. Shares of the company reached a 52-week high of $7.13 on 07/09/25 and a 52-week low of $0.46 on 04/09/25.
Support And Resistance Levels for ProKidney Corp (PROK)
According to the 24-hour chart, there is a support level at 2.35, which, if violated, would cause prices to drop to 2.22. In the upper region, resistance lies at 2.59. The next price resistance is at 2.71. RSI (Relative Strength Index) is 53.85 on the 14-day chart, showing neutral technical sentiment.
Is ProKidney Corp subject to short interest?
Stocks of ProKidney Corp saw a sharp rise in short interest on 2025-11-28 jumping by 2.49 million shares to 14.79 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 12.29 million shares. A jump of 16.85% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.67 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.67.
Which companies own the most shares of ProKidney Corp (PROK)?
In terms of ProKidney Corp share price expectations, FactSet research, analysts set an average price target of 5 in the next 12 months, up nearly 112.77% from the previous closing price of $2.35. Analysts anticipate ProKidney Corp stock to reach 6 by 2025, with the lowest price target being 3. In spite of this, 6 analysts ranked ProKidney Corp stock as Buy at the end of 2025. On March 07, 2024, Morgan Stanley assigned a price target of “an Equal-weight” to the stock and resumed coverage with a $3.
